


Some people prefer a monthly injection because it eliminates the need for daily dosing. Others choose treatment with Sublocade when they experience side effects from naloxone, want to taper off medication over time, or have concerns about dental effects from sublingual medications. If you’re exploring injectable treatment options, learn more about Sublocade treatment and how pharmacy-administered injections compare with daily sublingual buprenorphine treatment.
Whichever approach fits your needs, Ophelia can help. We offer online treatment primarily using buprenorphine/naloxone (Suboxone®), along with alternatives and pharmacist-administered Sublocade in select Pennsylvania locations. Our care team will walk you through your options and determine which treatment best fits into your daily life.



















Our clinicians provide evidence-based OUD treatment primarily using buprenorphine/naloxone (Suboxone). Alternatives like Zubsolv or generic buprenorphine may be prescribed for certain individuals according to established clinical guidelines. We continue monitoring your response to treatment and adjust your care plan when needed.
If clinically indicated, you will receive a treatment plan tailored to your medical history, goals, and preferences. Most Ophelia patients can start and continue buprenorphine treatment entirely through secure video visits. If something comes up between scheduled visits, our care coordination team is available seven days a week.
For patients in select Pennsylvania locations who are stabilized on daily buprenorphine, our care team can discuss whether Sublocade for opioid addiction (or another injectable like Brixadi) is an appropriate next step.
Our clinicians specialize in MOUD, or Medications for Opioid Use Disorders, and MAT, or Medication-Assisted Treatment. Ophelia understands how cravings and withdrawal respond to buprenorphine, how relapse risk shifts over time, and how co-occurring mental health conditions can affect treatment. Your care plan is guided by providers who understand what works and how to tailor treatment around your unique needs.


Sublocade is an extended-release injectable form of buprenorphine used to manage OUD. Administered by a clinician on a monthly basis, the injection releases medication gradually to help reduce cravings and withdrawal symptoms over the following weeks.
Not entirely. Because Sublocade is an injection, it must be administered by a clinician in person. Ophelia offers Sublocade for opioid addiction in select Pennsylvania locations. Alternatively, daily buprenorphine options like Suboxone are available fully through virtual treatment for individuals in other locations.
No. Sublocade is a clinician-administered injection, so you can’t take it at home like you can with a daily buprenorphine-based medication. If having the option to take your medication at home is essential, daily buprenorphine may be a better fit.
A monthly Sublocade injection provides a continuous release of medication to help manage your cravings and withdrawal symptoms. This sustained-release formula has a terminal half-life of 43 to 60 days, meaning it could take up to 10 months for your body to fully eliminate it.
Buprenorphine is taken sublingually up to four times a day, which requires daily medication management. While Sublocade eliminates the need for daily dosing, buprenorphine tablets or films can be legally prescribed through telehealth. This means buprenorphine treatment is more flexible, private, and accessible for many people.
In most cases, yes. Clinicians typically start patients on a daily buprenorphine medication like Suboxone, Zubsolv, or a generic version first. This allows them to confirm that you can tolerate the medication and that your symptoms are well managed before they move you to a long-acting injection.
Many insurance plans offer some level of coverage for Sublocade, including Medicaid, Medicare, and commercial coverage. But the medication must be administered in a clinical setting, which means its cost and coverage tend to vary. The Ophelia team reviews your specific plan to help you understand your coverage and options prior to starting treatment.
Ophelia offers Sublocade in select Pennsylvania locations. If you're in an eligible location and stabilized on daily buprenorphine, you can discuss whether Sublocade or Brixadi is an option with your care team. If you live outside of these locations, we offer nationwide telehealth treatment for OUD primarily using buprenorphine/naloxone (Suboxone). Depending on your needs, our clinicians may also prescribe alternatives like Zubsolv or buprenorphine-only.
